Biotechnology at Rutgers University-New Brunswick

Rutgers' biotechnology program stands out nationally but looks average within New Jersey—though with only three biotech programs statewide, that comparison means less than usual. The real story is that graduates earn nearly $10,000 more than the national median for biotech majors (87th percentile nationally), while carrying debt that's well below typical levels. A debt-to-earnings ratio of 0.47 means students owe less than half their first-year salary, which is comfortable territory for STEM graduates.

The caveat here matters: with fewer than 30 graduates in the dataset, these numbers could shift significantly with a larger sample. A few exceptionally high or low earners can skew small cohorts. That said, Rutgers' strong reputation in the life sciences and its location near pharmaceutical hubs in central New Jersey create plausible reasons why these earnings would hold up. The program sits at a selective flagship university with solid research infrastructure.

For families weighing this option, the fundamentals look sound—manageable debt paired with above-average starting salaries. Just recognize you're looking at a snapshot from a small graduating class rather than a firmly established pattern. If your child is genuinely interested in biotechnology and wants to stay in the Northeast's biotech corridor, this program offers a reasonable financial foundation without the crushing debt loads seen in many STEM fields.